Humanigen Inc (HGENQ)

[cowtown jay]

It should be about time for interim analyses for CMML and Acute GvHD, plus time for news as to whether we resubmitted our covid EUA application to the FDA, with a copy to the MHRA, based on ACTIV-5 supplemental safety and efficacy data, as well as comparable date to Gohibic for stage 6 patients.

So I hope we'll hear news about regulatory progress, as well as news related to our purchase of the Baudax shares, when our 10-Q is released in the next week, or two.

In the meantime, we'll just continue to communicate our thoughts and ideas, as we are now doing.